Monographie - Pentamidine isetionate

Zadnji put ažurirano :
08/05/2024

Pentamidine isetionate

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

DBL Pentamidine isetionate	Malezija
Manicare	Argentina
Nebupent	S A D
Pentacarinat	Austrija, Belgija, Danska, Finska, Francuska, Grčka, Italija, Kolumbija, Luksemburg, Nizozemska, Njemačka, Novi Zeland, Španjolska, Švedska, Švicarska, Velika Britanija
Pentam	S A D
Pentamidina	Argentina, Španjolska
Pentamidine isethionate	Australija, Kanada, Malezija, S A D
Pentamina	Portugal

Bibliografija : Pentamidine isetionate

	Vrsta	Publikacija
36	Časopis	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Časopis	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Časopis	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Časopis	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Časopis	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Časopis	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Časopis	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratorija	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Časopis	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Časopis	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Časopis	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Časopis	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratorija	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratorija	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratorija	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratorija	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales